Clinical trial
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With…
NCT00415064 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00415064 |
|---|---|
| Title | Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma |
| Official title | An Open-Label Phase I Study of the Safety of Perifosine in Combination With Lenalidomide and Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Perifosine, Lenalidomide, Dexamethasone |
| Enrollment | 32 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Dec 22, 2006 |
| Last update posted | Jul 6, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: